CZ409198A3 - Místní gelový prostředek a jeho použití - Google Patents

Místní gelový prostředek a jeho použití Download PDF

Info

Publication number
CZ409198A3
CZ409198A3 CZ984091A CZ409198A CZ409198A3 CZ 409198 A3 CZ409198 A3 CZ 409198A3 CZ 984091 A CZ984091 A CZ 984091A CZ 409198 A CZ409198 A CZ 409198A CZ 409198 A3 CZ409198 A3 CZ 409198A3
Authority
CZ
Czechia
Prior art keywords
gel composition
composition according
topical gel
acid
mixtures
Prior art date
Application number
CZ984091A
Other languages
Czech (cs)
English (en)
Inventor
Nigel John Leeves
François Riahi
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of CZ409198A3 publication Critical patent/CZ409198A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CZ984091A 1996-06-27 1997-06-24 Místní gelový prostředek a jeho použití CZ409198A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9613457.2A GB9613457D0 (en) 1996-06-27 1996-06-27 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
CZ409198A3 true CZ409198A3 (cs) 1999-04-14

Family

ID=10795959

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ984091A CZ409198A3 (cs) 1996-06-27 1997-06-24 Místní gelový prostředek a jeho použití

Country Status (14)

Country Link
EP (1) EP0973522A1 (no)
JP (1) JPH11513037A (no)
KR (1) KR20000022245A (no)
AU (1) AU3643897A (no)
BR (1) BR9709997A (no)
CA (1) CA2258199A1 (no)
CZ (1) CZ409198A3 (no)
GB (1) GB9613457D0 (no)
HU (1) HUP9903835A3 (no)
IL (1) IL127426A0 (no)
NO (1) NO986042L (no)
NZ (1) NZ333180A (no)
TR (1) TR199802701T2 (no)
WO (1) WO1997049405A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274592B1 (en) * 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
HUP9802716A3 (en) * 1998-11-25 2000-08-28 Chinoin Gyogyszer Es Vegyeszet Pharmaceutical composition of analgesic activity
US6368618B1 (en) 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
US9012402B1 (en) 2014-06-11 2015-04-21 James Blanchard Gel for topical delivery of NSAIDs to provide relief of musculoskeletal pain and methods for its preparation
US10821075B1 (en) 2017-07-12 2020-11-03 James Blanchard Compositions for topical application of a medicaments onto a mammalian body surface

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559343A (en) * 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
US5558876A (en) * 1995-03-29 1996-09-24 Alcon Laboratories, Inc. Topical ophthalmic acidic drug formulations

Also Published As

Publication number Publication date
WO1997049405A1 (en) 1997-12-31
NO986042D0 (no) 1998-12-22
CA2258199A1 (en) 1997-12-31
GB9613457D0 (en) 1996-08-28
HUP9903835A3 (en) 2001-03-28
BR9709997A (pt) 1999-08-10
HUP9903835A2 (hu) 2000-10-28
TR199802701T2 (xx) 1999-03-22
EP0973522A1 (en) 2000-01-26
IL127426A0 (en) 1999-10-28
AU3643897A (en) 1998-01-14
NZ333180A (en) 2000-09-29
JPH11513037A (ja) 1999-11-09
KR20000022245A (ko) 2000-04-25
NO986042L (no) 1999-02-26

Similar Documents

Publication Publication Date Title
AU2001246484B2 (en) Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails
Chaudhary et al. Preparation and evaluation of novel in situ gels containing acyclovir for the treatment of oral herpes simplex virus infections
ES2590258T3 (es) Preparación antiinflamatoria y analgésica para uso externo
US8822537B2 (en) Topical ketoprofen composition
DK2586426T3 (en) Carboxyvinyl polymer-containing nanopartikelsuspensioner
PE20001049A1 (es) Complejos estables de compuestos escasamente solubles
WO2019014380A1 (en) PLATFORMS FOR TOPICAL ADMINISTRATION OF MEDICAMENTS AND METHODS OF PREPARATION THEREOF
JP4004182B2 (ja) 乳化組成物
KR19990007837A (ko) 눈의 전방 챔버에서 축동제 및 산동제의 조절 방출법
EP0336200B1 (en) Pharmaceutical compositions of piroxicam in aqueous solutions and process for their preparation
CZ409198A3 (cs) Místní gelový prostředek a jeho použití
CZ284007B6 (cs) Protivirově aktivní farmaceutická emulze oleje ve vodě obsahující 9-{(2-hydroxyethoxy)metyl}quanin (acyclovir) nebo jeho sole nebo estery
ES2206956T3 (es) Composicion farmaceutica liquida acuosa que contiene un derivado de benzopirano como componente principal.
BRPI0609535A2 (pt) uso de oxaprozina na preparação de um medicamento para o tratamento de eczemas
ES2375784B1 (es) Gel de ácido tranexámico
AU8878298A (en) Method for preparing pharmaceutical formulations
PT2424538E (pt) Utilização de alopurinol para o tratamento de uma reação cutânea mão-pé
BR112020016597A2 (pt) Composição aquosa, usos de pelo menos um solvente orgânico, método para preparar uma composição, garrafa e kit
JP2000273016A5 (no)
WO2021124044A1 (en) Pharmaceutical composition of cyclooxygenase – 2 inhibitors
EP4087559A1 (en) Topical compositions containing rofecoxib and methods of making and using the same
AU2019208350A1 (en) Suspension compositions of multi-target inhibitors
CN1223584A (zh) 含非类固醇抗炎药和黄嘌呤衍生物组合的局部外用的凝胶组合物
JPS58152811A (ja) インドメタシン点眼組成物
CA2966843A1 (en) Sprayable analgesic compositions

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic